Country: Svizzera
Lingwa: Ġermaniż
Sors: Swissmedic (Swiss Agency for Therapeutic Products)
aesculus hippocastanum (HAB) D8, agave americana e foliis recentibus D12 (HAB 2a), araneus diadematus ex animal totum D20 (HAB 4b), aristolochia clematitis (HAB) D24, carbo animalis (HAB) D20, conium maculatum (HAB) D30, galium aparine (HAB) D3, solanum dulcamara (HAB) D6, spongilla lacustris (HAB) D20, viscum album (HAB) D4
Regena AG
aesculus hippocastanum (HAB) D8, agave americana e foliis recentibus D12 (HAB 2a), araneus diadematus ex animal totum D20 (HAB 4b), aristolochia clematitis (HAB) D24, carbo animalis (HAB) D20, conium maculatum (HAB) D30, galium aparine (HAB) D3, solanum dulcamara (HAB) D6, spongilla lacustris (HAB) D20, viscum album (HAB) D4
Tropfen zum Einnehmen
aesculus hippocastanum (HAB) D8 0.10 ml, agave americana e foliis recentibus D12 (HAB 2a) 0.10 ml, aranea diadema ex animale toto D20 (HAB 4b) 0.10 ml, aristolochia clematitis (HAB) D24 0.10 ml, carbo animalis (HAB) D20 0.10 ml, conium maculatum (HAB) D30 0.10 ml, galium aparine (HAB) D3 0.10 ml, solanum dulcamara (HAB) D6 0.10 ml, spongilla lacustris (HAB) D20 0.10 ml, viscum album (HAB) D4 0.10 ml, aqua purificata, ethanolum 96 per centum 0.39 g, ad solutionem 1 ml, corresp. 47 guttae, corresp. ethanolum 50 % V/V.
D
Homöopathische Arzneimittel
Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)
zugelassen
2011-03-31